PFS Investments’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

PFS Investments’s Portfolio SWAV Stock Details SWAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$1.73M	Buy	+6,060	New	+$1.68M	0.03%	342

Other funds holding SWAV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

PFS Investments's SWAV Position: Q2 2023 in Review

PFS Investments opened a new position in Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2023: 6,060 shares worth $1.73M. The stake represents 0.03% of the portfolio and ranks #342 among its holdings.

458 funds tracked by Wall St. Rank hold SWAV as of Q2 2023.

PFS Investments held 6,060 shares of Shockwave Medical, Inc. Common Stock worth $1.73M as of Q2 2023.
Shockwave Medical, Inc. Common Stock was a new PFS Investments position in Q2 2023.
Shockwave Medical, Inc. Common Stock made up 0.03% of PFS Investments's portfolio in Q2 2023, its #342 holding.
458 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2023.

Based on PFS Investments's 13F filing for Q2 2023, filed 14 Aug 2023.